LRCX vs SGRY · P/E 71, rev $23.23B vs rev $1.66B
Lam Research Corp (LRCX) versus Surgery Partners Inc (SGRY) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Surgery Partners Inc (SGRY) is a medical care facilities company listed on US.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Latest reported SGRY revenue for 2026-06-30 was $1.66B. Net income was -$50.9M. SGRY currently screens at market cap $1.79B.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. SGRY currently screens at market cap $1.79B.
Not investment advice. Open the LRCX and SGRY stock pages for the full models.
Not investment advice.